Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @embojournal
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @embojournal
-
Prikvačeni tweet
Issue 3: Spotlights on torpedos terminating transcription & nuclear stress bodies aiding intron retention; respiratory supercomplexes, ribosome stalling, all-inclusive adipocyte vesicles & 2x biomechanical events in tissue replacement Cover:
@LabSchnittger http://embopress.org/toc/14602075/2020/39/3 …pic.twitter.com/aseo37yi02
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New resource: Hoffmann et al
@mpiib_berlin establish conditions for long-term cultivation of primary#ovarian#cancer#organoids, allowing analysis of#niche-signaling requirements vs. driver-mutation dependence http://embopress.org/doi/10.15252/embj.2019104013 …pic.twitter.com/Ws1fllUGMr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EMBO Journal proslijedio/la je Tweet
The first 2019-nCoV
#coronavirus structure of the main protease has been released today (6LU7). This is a result of a huge effort from Prof. Rao's group@ShanghaiTechUni. For more information on the structure and related data available in the PDB visit https://www.wwpdb.org/news/news?year=2020#5e39e03fa5007a04a313edc3 …pic.twitter.com/dbM291atZk
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What sets the capacity of adult
#neural#stemcell niches to hold a specific number of cells? Conditional deletion of#matricellular protein CCN1 reveals role of#ependymal cells secreting this factor in the ventricular/subventricular zone http://embopress.org/doi/10.15252/embj.2019101679 …pic.twitter.com/fYaZTEnJGr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EMBO Journal proslijedio/la je Tweet
To view the referee reports, click on the blue “Peer Reviews” tab to the right of the preprint title. This brings up a
@hypothes_is sidebar containing four items: a report from each of the three reviewers and a reply from the authors. Feel free to comment and share. (3/n)pic.twitter.com/PQyt2jpbt9
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EMBO Journal proslijedio/la je Tweet
We’re excited to share our first
#RefereedPreprint: “Unconventional kinetochore kinases KKT2 and KKT3 have a unique zinc finger that promotes their kinetochore localization.” https://www.biorxiv.org/content/10.1101/2019.12.13.875419v1#annotations:vvrwXkZ-EeqiSk-WEm0-Vw … (1/n)Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Yeast osmostress & pheromone signaling are a paradigm for MAP kinase pathway cross-talk – but how to achieve specificity? Saito, Tatebayashi et al find new transmembrane-osmosensor-independent mechanism insulating Hog1 MAPK from pheromone-sensing pathway http://embopress.org/doi/10.15252/embj.2019103444 …pic.twitter.com/3KtsJLoWtO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EMBO Journal proslijedio/la je Tweet
I have to give a talk at a PI meeting tomorrow (and should be working on my slides), but here is our experience with
@ReviewCommons so far. Note that this is our personal experience and N=1 (1/n).Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Collaboration of Waldemar Vollmer,
@TannekedenBlaau, Athanasios Typas labs identifies E. coli outer membrane lipoprotein Nlpl as scaffold coordinating#peptidoglycan synthase and hydrolases to allow#bacterial cell wall growth http://embopress.org/doi/10.15252/embj.2019102246 …pic.twitter.com/OwOcIWhFAS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EMBO Journal proslijedio/la je Tweet
01/2020 Issue --> http://www.embopress.org/toc/17444292/2020/16/1 … The cover (by
@TeamSciStories) highlights two automated sample preparation methods for#phosphoproteomics -R2-P2 from@juditvr@uwgenome- &#clinicalproteomics -autoSP3 from J Krijgsveld@DKFZ-#proteomicspic.twitter.com/u8OSd7LF1Y
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EMBO Journal proslijedio/la je Tweet
2020s are already a bumper decade for rhomboid-related papers… This excellent one from
@KvidoStrisovsky group suggests bacterial rhomboids can have#ERAD-like roles https://www.ncbi.nlm.nih.gov/pubmed/31930742@embojournalpic.twitter.com/YNboGEFWXZ
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EMBO Journal proslijedio/la je Tweet
Rapidly sharing research data is essential during an epidemic. All findings on the new
#coronavirus should be:
Shared immediately with @WHO
Available online before peer review
Open access when published
Read more
https://wellc.me/38T5zbp | #OutsmartEpidemicspic.twitter.com/5mQvk1JK16
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EMBO Journal proslijedio/la je Tweet
Timely reminder that the study of protein phosphorylation is a truly international endeavour! Might even make a good flag! More magic from
@ClaireEEyers@jeroen_claus@phospho@embojournalpic.twitter.com/8Eh1h7X9OE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Once we received your manuscript
@embojournal, we know your work was done before that competing paper came out just now - applies also when transferring further to other@EMBOpress journals or when you’ve posted recent#preprint on@biorxivpreprint http://embopress.org/policies pic.twitter.com/MkPlcp1bTW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EMBO Journal proslijedio/la je Tweet
Abstract submission (30 Jan) and registration deadlines (20 Feb) for
@EMBO /@embl Symposium "The Four-Dimensional Genome" are approaching. Our director Jan-Michael Peters will be present and give a talk (in case you need to be convinced).https://twitter.com/EMBLEvents/status/1216715772594024454 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
“Seeking fresh assessment elsewhere” can be a drag… that’s why
@EMBOpress journals not only offer informed in-house transfers, but also consider referee reports from outside journals on a case-by-case basis! http://embopress.org/policies pic.twitter.com/zLgcB0qXAU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EMBO Journal proslijedio/la je Tweet
#journalclub This paper suggests a role of ER-phagy receptor FAM134B oligomerization in ER scission! https://www.embopress.org/doi/full/10.15252/embj.2019102608 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EMBO Journal proslijedio/la je Tweet
A study by
@Foijer_lab@researchumcg finds that inhibition of Src kinase is synergistically toxic with spindle assembly checkpoint defects, revealing a possible Achilles heel for chromosomal instable cancer cells.https://www.life-science-alliance.org/content/3/2/e201900499 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EMBO Journal proslijedio/la je Tweet
Routine Reminder: Do not use journal-based metrics as a surrogate measure of the quality of individual research articles, to assess an individual scientist’s contributions, or in hiring, promotion, or funding decisions. Sign DORA: http://ow.ly/Hcvy50y6joR pic.twitter.com/WRNmlU23Y9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EMBO Journal proslijedio/la je Tweet
Excited to share our latest collaborative work on Cav1.2
#ionchannel regulation by α‐actinin. Full (open) access is currently available!!! Go get your copy. https://www.embopress.org/doi/10.15252/embj.2019102622#.Xi7-k8MuLvk.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
Submit your abstract by 30 January